Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Pharma and Healthcare Fund · Direct ✕Bank of India Consumption Fund · Direct ✕

Growth of ₹10,000

Basics

Invesco India Pharma and Healthcare FundBank of India Consumption Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseInvescoBank of India
NAV₹10.7800₹11.7700
NAV date20 Nov 202620 Nov 2026
History2 months1.9 years
Expense ratio1.9%1.5%
StarsNot ratedNot rated
Growth Score——

Returns

Invesco India Pharma and Healthcare FundBank of India Consumption Fund
1 month+19.78%+8.78%
3 months—+1.47%
6 months—+10.10%
YTD—+4.25%
1 year—+2.79%
3 years (CAGR)——
5 years (CAGR)——
10 years (CAGR)——
Since launch+7.58%+8.80%

Risk

Invesco India Pharma and Healthcare FundBank of India Consumption Fund
Volatility——
Downside volatility——
Sharpe——
Sortino——
Calmar——
Return / risk——
Deepest fall−11.39%−15.16%
Days to recover14133
Below its high+0.00%+0.00%

Against benchmark

Invesco India Pharma and Healthcare FundBank of India Consumption Fund
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

Invesco India Pharma and Healthcare FundBank of India Consumption Fund
Best 1-year—+16.83%
Middle 1-year—+3.46%
Worst 1-year—−8.07%
1-year periods with a loss—20.0%
Middle 3-year——
Positive months——
Best day+3.62%+3.12%
Worst day−2.74%−3.23%
Worst 5% day−1.53%−1.35%
Positive days48.9%47.3%
NAVs a year48247

SIP of ₹10,000 a month

Invesco India Pharma and Healthcare FundBank of India Consumption Fund
5-year XIRR——
5-year value——
3-year XIRR——
1-year XIRR—+14.56%

Holdings overlap i

Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
  • Invesco India Pharma and Healthcare Fund: no monthly portfolio filing from Invesco is loaded yet, so it is left out here.
  • Bank of India Consumption Fund: no monthly portfolio filing from Bank of India is loaded yet, so it is left out here.

Search Growth